Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

NME efficiently activates type I natural killer T cells

March 2, 2012

Johns Hopkins and ImmunoCellular Therapeutics enter licensing agreement for cancer antigen

March 1, 2012

OncoTherapy Science updates on cancer peptide vaccine pipeline

March 1, 2012

Advaxis reports data from first cohort in phase II ADXS-HPV trial

Feb. 28, 2012

Stem CentRx reports new APCDD1-binding antibodies

Feb. 28, 2012

FDA approves protocol amendment to ARISER study

Feb. 27, 2012

Phase I trials assess Listeria-based vaccines in patients with cancer

Feb. 23, 2012

Trials indicate ipilimumab can be administered with cancer vaccines

Feb. 20, 2012

New candidate cancer immunotherapies developed in France

Feb. 14, 2012

Scientists disclose new CD27-targeted candidate immunotherapeutics

Feb. 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...